Mukka Proteins Falls 16.31%: 3 Key Factors Driving the Sharp Decline

15 September 2026: Weak Start Amid Broader Market Decline

Mukka Proteins opened the week at Rs.31.35, down 2.25% from the previous close of Rs.32.07. This decline was sharper than the Sensex’s 1.69% drop to 35,169.62, signalling early weakness in the stock. The volume of 2,12,002 shares indicated moderate trading interest. The stock’s underperformance relative to the broader market suggested company-specific pressures beginning to weigh on investor sentiment.

16 September 2026: Sharp Drop Despite Sensex Gains

On 16 September, Mukka Proteins fell further by 5.39% to Rs.29.66, while the Sensex gained 0.30% to 35,276.25. This divergence highlighted growing selling pressure on the stock amid a generally positive market environment. The volume dropped to 75,728 shares, reflecting reduced investor participation. The stock’s decline below its 5-day moving average indicated short-term bearish momentum despite longer-term support levels remaining intact.

17 September 2026: Lower Circuit Hit Amid Heavy Selling Pressure

Mukka Proteins plunged to its lower circuit limit on 17 September, closing at Rs.28.18, down 4.99% on the day. This marked the third consecutive day of losses and a cumulative decline of nearly 11.97% over three sessions. The stock’s maximum daily loss reached 2.64% intraday, hitting the lower price band of Rs.28.06. Despite the FMCG sector gaining 0.51% and the Sensex rising marginally by 0.46%, Mukka Proteins underperformed significantly, reflecting intense selling pressure and waning investor confidence.

Trading volumes were subdued at 88,840 shares, with delivery volumes dropping sharply, signalling reduced long-term investor participation. The stock remained above its longer-term moving averages but fell below the 5-day average, indicating short-term bearishness. The micro-cap status and market capitalisation of Rs.858 crore contribute to heightened volatility and thinner market depth.

18 September 2026: Second Consecutive Lower Circuit Amid Panic Selling

The stock again hit the lower circuit on 18 September, closing at Rs.26.84, down 4.76%. The maximum intraday loss was 4.88%, with the stock trading in a narrow range near the lower price band of Rs.27.26, triggering an automatic trading halt. Despite a turnover of Rs.1.52 crore on 5.56 lakh shares, delivery volumes remained low, indicating speculative trading rather than long-term accumulation.

Mukka Proteins underperformed its FMCG peers by 4.6% and the Sensex, which gained 0.52%. The stock’s four-day consecutive decline amounted to over 16%, underscoring significant near-term challenges. Technically, the stock remains above its 50-day and longer moving averages but below the 5-day and 20-day averages, reflecting sustained bearish momentum.

Valuation Shift to Very Attractive Amid Market Volatility

Despite the recent price weakness, Mukka Proteins’ valuation metrics improved notably during the week, with its price-to-earnings (P/E) ratio at 12.23, significantly lower than peers such as Apex Frozen Food (22.23) and Essex Marine (12.2). The price-to-book value (P/BV) ratio of 1.69 suggests the stock is trading close to its net asset value, enhancing its appeal for value investors.

Enterprise value multiples also support this view, with an EV to EBITDA ratio of 10.57 and EV to EBIT of 12.04, both below comparable FMCG companies. The company’s PEG ratio of 0.21 further indicates earnings growth expectations are well supported by the current price. Operational returns remain steady, with ROCE at 8.05% and ROE at 10.37%, reflecting consistent profitability and efficient capital use.

Year-to-date, Mukka Proteins has delivered a 17.37% return, outperforming the Sensex’s negative 12.80% over the same period. Over the past month, the stock gained 2.29% while the Sensex declined 4.39%, underscoring relative resilience despite recent volatility.

Daily Price Comparison: Mukka Proteins Ltd vs Sensex

Key Takeaways

Significant Downside Pressure: Mukka Proteins endured a steep 16.31% weekly decline, markedly underperforming the Sensex’s modest 0.41% fall. Consecutive lower circuit hits on 17 and 18 September highlight intense selling pressure and investor panic.

Volume and Liquidity Dynamics: Declining delivery volumes amid high traded volumes suggest speculative trading and reduced long-term investor conviction. The micro-cap status contributes to volatility and thinner market depth.

Valuation and Fundamentals: Despite price weakness, valuation metrics improved to a very attractive level, with P/E and EV multiples below peers. The Mojo Score upgrade to ‘Hold’ reflects cautious optimism about the company’s fundamentals and recovery potential.

Technical Outlook: The stock remains above longer-term moving averages but below short-term averages, indicating short-term bearish momentum amid longer-term support zones around Rs.27-28.

Conclusion

Mukka Proteins Ltd’s sharp 16.31% weekly decline amid heavy selling and two consecutive lower circuit hits underscores the challenges faced by micro-cap stocks in volatile markets. While the stock’s valuation has shifted to a very attractive level and the Mojo Grade was upgraded to ‘Hold’, the immediate technical and volume signals point to sustained short-term weakness. The stock’s relative underperformance against the FMCG sector and Sensex highlights company-specific concerns that investors should monitor closely. Given the micro-cap nature and recent volatility, cautious participation is advised, with attention to price stabilisation and any emerging positive catalysts.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →